This review provides an overview of the diagnosis, management, and prevention of heart failure with preserved ejection fraction, highlighting that disease-modifying treatment options remain sparse.
This review summarizes the diagnosis, management, and prevention of HFpEF, a growing condition with sparse disease-modifying treatments, for general physicians.
Heart failure with preserved ejection fraction (HFpEF) represents a heterogeneous collection of conditions that are unified by the presence of a left ventricular ejection fraction ≥50%, evidence of impaired diastolic function and elevated natriuretic peptide levels, all within the context of typical heart failure signs and symptoms. However, while HFpEF is steadily becoming the predominant form of heart failure, disease-modifying treatment options for this population remain sparse. This review provides an overview of the diagnosis, management and prevention of HFpEF for general physicians.
Harper et al. (Sun,) conducted a review in Heart failure with preserved ejection fraction (HFpEF). This review provides an overview of the diagnosis, management, and prevention of heart failure with preserved ejection fraction, highlighting that disease-modifying treatment options remain sparse.